Douglas Williams
Chief Executive Officer en CODIAK BIOSCIENCES .
Fortuna: 115 230 $ al 31/03/2024
Origen de la red de primer grado Douglas Williams.
| Entidad | Tipo de entidad | Industria | |
|---|---|---|---|
86
| Public Company | Pharmaceuticals: Major | 86 |
| Public Company | Pharmaceuticals: Major | 38 | |
31
| Public Company | Pharmaceuticals: Major | 31 |
Immunex Corp.
 Immunex Corp. BiotechnologyHealth Technology Immunex Corporation is a leading biopharmaceutical company dedicated to improving lives through immune system science innovation
31
| Subsidiary | Biotechnology | 31 |
29
| Public Company | Pharmaceuticals: Major | 29 |
| Private Company | Pharmaceuticals: Major | 27 | |
ZymoGenetics, Inc.
 ZymoGenetics, Inc. Pharmaceuticals: MajorHealth Technology ZymoGenetics, Inc. develops protein based drugs. It focuses on the discovery, development, manufacture, and commercialization of therapeutic proteins for the treatment of human diseases, including homeostasis, inflammatory and autoimmune diseases, cancer, and viral infections. The company was founded by Earl W. Davie, Benjamin D. Hall and Michael Smith in 1981 and is headquartered in Seattle, WA.
26
| Extinct | Pharmaceuticals: Major | 26 |
| Public Company | Pharmaceuticals: Major | 20 | |
16
| Subsidiary | Pharmaceuticals: Major | 16 |
Anadys Pharmaceuticals, Inc.
 Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ.
13
| Subsidiary | Pharmaceuticals: Major | 13 |
| Public Company | Pharmaceuticals: Major | 13 | |
Stablix, Inc.
 Stablix, Inc. Miscellaneous Commercial ServicesCommercial Services Stablix, Inc. is a biotechnology company based in New York, NY. The company is focused on establishing a new paradigm for tackling diverse diseases by harnessing the power of the body's own cellular machinery through targeted protein stabilization. Stablix's restored™ platform generates heterobifunctional small molecules (restoracs™) that selectively recruit active deubiquitinases (dubs) to target proteins for precise removal of ubiquitin to restore protein function. The company is currently advancing its lead programs towards clinical studies. The company's platform is based on the work of Henry Colecraft, Ph.D., professor of physiology and cellular biophysics, and professor of pharmacology, Columbia University Irving Medical Center. Stablix was founded in June 2021 with a $63 million series A led by founding investor Versant Ventures with New Enterprise Associates (NEA), Cormorant Asset Management, Euclidean Capital, and Alexandria Venture Investments. Stuart Anthony Kingsley has been the CEO of the company since 2022.
10
| Holding Company | Miscellaneous Commercial Services | 10 |
| Subsidiary | Pharmaceuticals: Major | 9 | |
| Private Company | Financial Conglomerates | 8 | |
Cytoimmune Therapeutics, Inc.
 Cytoimmune Therapeutics, Inc. BiotechnologyHealth Technology Cytoimmune Therapeutics, Inc. is a clinical-stage biotechnology company founded in 2017 and based in Toa, Japan. The American company is focused on developing a pipeline of NK cell therapies for various types of cancer, including lung cancer, acute myeloid leukemia, solid tumors, and multiple myeloma. The private company's lead product, Cyto-102, is a track-NK cell therapy that aims to enter clinical trials in combination with atezolizumab for non-small cell lung cancer in 2022. Cytoimmune Therapeutics also offers cell therapy development and clinical manufacturing services to biotechnology companies and academia. The company's state-of-the-art clinical cell manufacturing facility is custom-built to support the development and commercialization of cutting-edge T cell or NK cell therapies. The company was founded in 2017 by Michael A. Caligiuri, William Michael Rosellini, and Jianhua Yu, Ph.D. José Eduardo Vidal has been the CEO of the company since 2021.
6
| Private Company | Biotechnology | 6 |
Xenikos BV
 Xenikos BV Medical SpecialtiesHealth Technology Xenikos BV focuses on the development of immunotherapies for the treatment of patients suffering from immune diseases. It is developing a combination of two toxin-loaded anti-T-cell antibodies, T-Guard, as a therapeutic tool for resetting the body's immune system in T-cell mediated diseases. The company was founded by Ypek van Oosterhout in September 2009 and is headquartered in Nijmegen, the Netherlands.
5
| Holding Company | Medical Specialties | 5 |
| Extinct | Medical Specialties | 4 | |
Cygnal Therapeutics, Inc.
 Cygnal Therapeutics, Inc. BiotechnologyHealth Technology Cygnal Therapeutics, Inc. develops drugs for cancer, immunological diseases and regenerative processes. The company was founded by Noubar Afeyan, Avak Kahvejian and Jordi Mata-Fink in 2017 and is headquartered in Cambridge, MA.
4
| Subsidiary | Biotechnology | 4 |
| Public Company | Biotechnology | 2 |
Gráfico Empresas conectadas de segundo grado
Relaciones con varias empresas
Empresas conectadas a Douglas Williams a través de su red personal
| Empresa | Sector | Personas relacionadas | Puesto principal |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Director of Finance/CFO Corporate Officer/Principal | |
| CELGENE | Biotechnology | Chief Executive Officer Director of Finance/CFO President General Counsel | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Chief Operating Officer General Counsel | |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Comptroller/Controller/Auditor Corporate Officer/Principal Corporate Officer/Principal | |
| Stanford University | College/University | Doctorate Degree Doctorate Degree Graduate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree | |
| Massachusetts Institute of Technology | College/University | Founder Corporate Officer/Principal Corporate Officer/Principal Undergraduate Degree Undergraduate Degree | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree Graduate Degree Doctorate Degree | |
| CYCLERION THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Director/Board Member Investor Relations Contact | |
The Scripps Research Institute
 The Scripps Research Institute Other Consumer ServicesConsumer Services The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California. | College/University | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
Whitehead Institute for Biomedical Research
 Whitehead Institute for Biomedical Research Miscellaneous Commercial ServicesCommercial Services Whitehead Institute for Biomedical Research provides research and technology services. Its services include biomedical, genomics, and genetics for students. The company was founded by Edwin C. Whitehead in 1982 and is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Director/Board Member Corporate Officer/Principal | |
Microbia, Inc.
 Microbia, Inc. Pharmaceuticals: MajorHealth Technology Microbia, Inc. engages in the development of microbial manufacturing technologies for the production of chemicals from renewable raw materials. The company is headquartered in DE. | Pharmaceuticals: Major | Founder Director/Board Member Director/Board Member Comptroller/Controller/Auditor | |
Mountain Group Capital LLC
 Mountain Group Capital LLC Investment ManagersFinance Mountain Group Capital LLC (Mountain Group Capital) is a venture capital investment firm founded in 2002. The firm is headquartered in Nashville, Tennessee. | Investment Managers | Founder Consultant / Advisor Corporate Officer/Principal Corporate Officer/Principal | |
| BLUEBIRD BIO, INC. | Biotechnology | Director of Finance/CFO Director/Board Member Director of Finance/CFO Corporate Officer/Principal | |
| ILLUMINA, INC. | Biotechnology | Director/Board Member Chairman Director/Board Member | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Corporate Officer/Principal Masters Business Admin Undergraduate Degree | |
| Dartmouth College | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
| INNOVIVA, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Corporate Officer/Principal | |
Accelerator Services Corp
 Accelerator Services Corp Investment ManagersFinance Accelerator Services Corp (Accelerator Services) is a venture capital firm founded in 2003 by Carl Weissman and Rodney F. Burgar. The firm is headquartered in Seattle, Washington. | Investment Managers | Consultant / Advisor Consultant / Advisor Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Founded in 1898, Northeastern University is a private research university located in the heart of Boston. Northeastern teaches worldwide experiential learning, urban engagement, and interdisciplinary research that meets global and societal needs. The University offers a range of undergraduate and graduate programs leading to degrees through the doctorate in nine colleges and schools. | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| Rutgers State University of New Jersey | College/University | Graduate Degree Graduate Degree Undergraduate Degree | |
| The University of Texas at Austin | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
| GENERATION BIO CO. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director of Finance/CFO General Counsel | |
| VERASTEM, INC. | Biotechnology | Director/Board Member Founder Corporate Officer/Principal | |
| NANOSTRING TECHNOLOGIES, INC. | Biotechnology | Chairman Director/Board Member Director of Finance/CFO | |
| University of California, Berkeley | College/University | Doctorate Degree Undergraduate Degree Graduate Degree | |
Arsenal Capital Management LP
 Arsenal Capital Management LP Investment ManagersFinance Arsenal Capital Management LP (Arsenal Capital) is a private equity subsidiary of Arsenal Capital Group LLC founded in 2000 by Terrence M. Mullen and Jeffrey B. Kovach. The firm is headquartered in New York. | Investment Managers | Director/Board Member Consultant / Advisor Consultant / Advisor | |
| INTERCEPT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
Emergent Product Development Seattle
 Emergent Product Development Seattle Pharmaceuticals: MajorHealth Technology Emergent Product Development Seattle discovers and develops biopharmaceutical products. It focuses on the discovery and development of novel medicines to treat inflammatory diseases and cancer. The company was founded by Peter A. Thompson, Jeffrey A. Ledbetter and Kendall M. Mohler in March 1999 and is headquartered in Seattle, WA. | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Mozart Therapeutics, Inc.
 Mozart Therapeutics, Inc. BiotechnologyHealth Technology Mozart Therapeutics, Inc. is a company focused on developing first-in-class disease-modifying therapies for autoimmune and inflammatory diseases, with a therapeutic focus on autoimmune mediated gastro-intestinal disorders. The company is based in Seattle, WA. The company utilizes a novel approach to restoring immune system function by targeting the CD8 T regulatory network. Mozart Therapeutics is advancing a pipeline of first-in-class ‘CD8 Treg modulators’ designed to restore durable immune balance. The CEO of the company is Katie Fanning. | Biotechnology | Chairman Director/Board Member | |
| The Fuqua School of Business | College/University | Masters Business Admin Masters Business Admin | |
| INNATE PHARMA | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
Ariosa Diagnostics, Inc.
 Ariosa Diagnostics, Inc. Medical/Nursing ServicesHealth Services Ariosa Diagnostics, Inc. offers diagnostics and genetic testing services. It focuses on improving overall patient care by developing and delivering genetic testing. The company was founded by John R. Stuelpnagel, Kenneth Song, Andrew J. Sparks, Michael E. Mitchell and Arnold R. Oliphant in 2008 and is headquartered in San Jose, CA. | Medical/Nursing Services | Director/Board Member Director/Board Member | |
ARCH Venture Partners LLC
 ARCH Venture Partners LLC Investment ManagersFinance ARCH Venture Partners LLC is a Venture Capital firm founded in 1986. The firm is headquartered in Chicago with additional office in Dublin. | Investment Managers | Private Equity Investor Private Equity Analyst | |
| Loyola University of Chicago | College/University | Undergraduate Degree Doctorate Degree | |
| SYROS PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| FATE THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chairman | |
Ren Pharmaceuticals, Inc.
 Ren Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ren Pharmaceuticals was formed in the fall of 2006 with the aim of bringing together talented and experienced people who are passionate about building a cardio-renal/renal- focused drug development company. Ren Pharmaceuticals closed a Series A financing in November 2006 with Sanderling Ventures, Venrock Associates and Amgen Ventures as investors. The company's R&D is currently located in South San Francisco, California. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree Corporate Officer/Principal | |
| CHINOOK THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member General Counsel | |
| VITAE PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Director/Board Member |
Estadísticas
Internacional
| Estados Unidos | 48 |
| Francia | 3 |
| Hong-Kong | 2 |
Sectorial
| Health Technology | 27 |
| Consumer Services | 15 |
| Finance | 7 |
| Commercial Services | 4 |
| Health Services | 2 |
Operativa
| Director/Board Member | 754 |
| Corporate Officer/Principal | 232 |
| Independent Dir/Board Member | 225 |
| Chairman | 146 |
| Founder | 88 |
Las relaciones más conectadas
| Insiders | |
|---|---|
| Steven Gillis | 58 |
| Srini Akkaraju Akkaraju | 54 |
| Terry McGuire | 51 |
| Nina Kjellson | 49 |
| Bryan Roberts | 44 |
| Charles Cooney | 37 |
| Friedrich von Bohlen und Halbach | 36 |
| Thomas Daniel | 35 |
| William Young | 32 |
| Ted Love | 31 |
| Pascale Witz | 31 |
| Kleanthis Xanthopoulos | 29 |
| Catherine Moukheibir | 29 |
| Felix Baker | 28 |
| Theo Melas-Kyriazi | 26 |
- Bolsa de valores
- Insiders
- Douglas Williams
- Conexiones Empresas
